RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
RBC Bioscience - Stock

RBC Bioscience ROA 2024

RBC Bioscience ROA

0.01

Ticker

6848.TWO

ISIN

TW0006848005

In 2024, RBC Bioscience's return on assets (ROA) was 0.01, a 78.49% increase from the 0 ROA in the previous year.

RBC Bioscience Aktienanalyse

What does RBC Bioscience do?

RBC Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding RBC Bioscience's Return on Assets (ROA)

RBC Bioscience's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing RBC Bioscience's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider RBC Bioscience's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in RBC Bioscience’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about RBC Bioscience Stock

What is the Return on Assets (ROA) of RBC Bioscience this year?

The Return on Assets (ROA) of RBC Bioscience is 0.01 undefined this year.

What was the ROA of RBC Bioscience compared to the previous year?

The ROA of RBC Bioscience has increased by 78.49% compared to the previous year.

What consequences do high ROA have for investors of RBC Bioscience?

A high ROA is advantageous for investors of RBC Bioscience, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in RBC Bioscience?

A low ROA can be unfavorable for investors of RBC Bioscience as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of RBC Bioscience affect the company?

An increase in ROA of RBC Bioscience can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of RBC Bioscience impact the company?

A reduction in the ROA of RBC Bioscience can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of RBC Bioscience?

Some factors that can influence the ROA of RBC Bioscience include revenue, operating costs, asset structure, and industry average.

Why is the ROA of RBC Bioscience important for investors?

The ROA of RBC Bioscience is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can RBC Bioscience take to improve ROA?

To improve ROA, RBC Bioscience can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does RBC Bioscience pay?

Over the past 12 months, RBC Bioscience paid a dividend of 1.12 TWD . This corresponds to a dividend yield of about 6.59 %. For the coming 12 months, RBC Bioscience is expected to pay a dividend of 1.12 TWD.

What is the dividend yield of RBC Bioscience?

The current dividend yield of RBC Bioscience is 6.59 %.

When does RBC Bioscience pay dividends?

RBC Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of RBC Bioscience?

RBC Bioscience paid dividends every year for the past 2 years.

What is the dividend of RBC Bioscience?

For the upcoming 12 months, dividends amounting to 1.12 TWD are expected. This corresponds to a dividend yield of 6.59 %.

In which sector is RBC Bioscience located?

RBC Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von RBC Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of RBC Bioscience from 8/11/2023 amounting to 1.12 TWD, you needed to have the stock in your portfolio before the ex-date on 7/13/2023.

When did RBC Bioscience pay the last dividend?

The last dividend was paid out on 8/11/2023.

What was the dividend of RBC Bioscience in the year 2023?

In the year 2023, RBC Bioscience distributed 0.909 TWD as dividends.

In which currency does RBC Bioscience pay out the dividend?

The dividends of RBC Bioscience are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von RBC Bioscience

Our stock analysis for RBC Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of RBC Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.